Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
8.78M
-
Shares change
-
-94K
-
Total reported value, excl. options
-
$71.2M
-
Value change
-
-$774K
-
Number of buys
-
14
-
Number of sells
-
-20
-
Price
-
$8.11
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q1 2022
48 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q1 2022.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.78M shares
of 92.4M outstanding shares and own 9.5% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.61M shares), MORGAN STANLEY (782K shares), BlackRock Inc. (780K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (709K shares), VANGUARD GROUP INC (692K shares), FMR LLC (646K shares), Fosun International Ltd (282K shares), STATE STREET CORP (231K shares), GEODE CAPITAL MANAGEMENT, LLC (217K shares), and NORTHERN TRUST CORP (136K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.